Treatment for Few Metastases | Oligo-Metastases Disease | Mark Scholz, MD | PCRI

'Oligometastatic' prostate cancer describes a situation in which a man has a small number of metastatic lesions in the bones, distant lymph nodes, or possibly organs like the liver or lungs. Historically, the treatment of oligometastatic disease was complicated by the limitations of imaging—that is, it was usually impossible to detect these lesions before they grew and multiplied. However, the advent of PSMA PET is opening up this stage of prostate cancer to earlier treatment and hopefully better outcomes. In this video, medical oncologist Mark Scholz, MD discusses how PSMA PET scans are changing how doctors are thinking about the treatment of oligometastatic disease. 0:10 What is oligometstatic prostate cancer? 2:00 What is the abscopal effect? 3:31 How have PSMA PET scans affected the treatment of men with oligometstatic disease? 4:41 How is oligometastatic disease usually treated? 7:12 How large does a metastatic lesion need to be to be discovered by a PSMA PET scan? 8:19 How does age affect the treatment of metastatic disease? 9:46 Is it possible for men with oligometastatic disease to be cured? Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org To learn more about prostate cancer visit http://www.pcri.org To receive the latest updates on prostate cancer and the PCRI, sign up for our online newsletter here: https://pcri.org/join Who we are: The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors. The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs. #ProstateCancer #Prostate #MarkScholzMD

Gleason 7 (4+3) #prostatecancer Treatments and Side Effects | #markscholzmd | PCRI
▶︎

Gleason 7 (4+3) #prostatecancer Treatments and Side Effects | #markscholzmd | PCRI

Newly Diagnosed Stage 4 #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI
▶︎

Newly Diagnosed Stage 4 #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI

Dr. Amar Kishan talks to the Prostate Cancer Information Group about high-dose SBRT and ADT.
▶︎

Dr. Amar Kishan talks to the Prostate Cancer Information Group about high-dose SBRT and ADT.

Immunotherapy for Prostate Cancer with Dr. John Bell
▶︎

Immunotherapy for Prostate Cancer with Dr. John Bell

Relapsed Prostate Cancer | 2026 Mid-Year Update | Eugene Kwon, MD + Mark Moyad, MD Q&A #PCRI
▶︎

Relapsed Prostate Cancer | 2026 Mid-Year Update | Eugene Kwon, MD + Mark Moyad, MD Q&A #PCRI

Prostate Cancer Cure Explained: PSA, Recurrence, and Survival
▶︎

Prostate Cancer Cure Explained: PSA, Recurrence, and Survival

Radiation Therapy for Oligometastatic Prostate Cancer
▶︎

Radiation Therapy for Oligometastatic Prostate Cancer

Treating Lymph Node #ProstateCancer Metastases | #MarkScholzMD #AlexScholz #PCRI
▶︎

Treating Lymph Node #ProstateCancer Metastases | #MarkScholzMD #AlexScholz #PCRI

Hormonal Therapy for Prostate Cancer
▶︎

Hormonal Therapy for Prostate Cancer

Bone Metastasis: Diagnosis and Scans | #MarkScholzMD #AlexScholz #PCRI
▶︎

Bone Metastasis: Diagnosis and Scans | #MarkScholzMD #AlexScholz #PCRI

Prostate Cancer: What You NEED To Know
▶︎

Prostate Cancer: What You NEED To Know

Advanced #ProstateCancer Treatments + Extended Q+A | #MarkScholzMD & #MarkMoyadMD #PCRI
▶︎

Advanced #ProstateCancer Treatments + Extended Q+A | #MarkScholzMD & #MarkMoyadMD #PCRI

Radical prostatectomy vs radiation therapy
▶︎

Radical prostatectomy vs radiation therapy

Beam Radiation Vs. Brachytherapy for #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI
▶︎

Beam Radiation Vs. Brachytherapy for #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI

Overview: PSA Recurrent Prostate Cancer
▶︎

Overview: PSA Recurrent Prostate Cancer

Is It Really Prostate Cancer? Rethinking Diagnosis, Biopsies, and the Gleason Score
▶︎

Is It Really Prostate Cancer? Rethinking Diagnosis, Biopsies, and the Gleason Score

Treating Micro-Metastatic #ProstateCancer Disease | #MarkScholzMD #AlexScholz #PCRI
▶︎

Treating Micro-Metastatic #ProstateCancer Disease | #MarkScholzMD #AlexScholz #PCRI

When Is Radiotherapy Right for Prostate Cancer?
▶︎

When Is Radiotherapy Right for Prostate Cancer?

Managing an Elevated PSA: Avoiding Unnecessary Prostate Biopsies
▶︎

Managing an Elevated PSA: Avoiding Unnecessary Prostate Biopsies

The Importance of Diagnosing and Treating Oligometastatic Prostate Cancer and ADT Usage
▶︎

The Importance of Diagnosing and Treating Oligometastatic Prostate Cancer and ADT Usage